Cognitive–Behavioral Therapy for Insomnia in Knee Osteoarthritis: A Randomized, Double‐Blind, Active Placebo–Controlled Clinical Trial. Issue 5 (May 2015)

• Record Type: Journal Article
• Authors: Smith, Michael T.; Finan, Patrick H.; Buenaver, Luis F.; Robinson, Mercedes; Haque, Uzma; Quain, Angela; McInrue, Erin; Han, Dingfen; Leoutsakis, Jeannie; Haythornthwaite, Jennifer A.
• Is Part Of: Arthritis & rheumatology. Volume 67:Issue 5(2015)
• Page Start: 1221
• Page End: 1233
• Publication Date: 2015-05
• Subjects: Arthritis -- Periodicals; Rheumatism -- Periodicals; 616.72
• DOI: 10.1002/art.39048
• Languages: English
• ISSNs: 2326-5191

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="art39048-sec-0001" sec-type="section"> <title>Objective</title> <p>Insomnia is prevalent among patients with knee osteoarthritis (OA). Research indicates that sleep disruption may amplify clinical pain by altering central pain modulation, suggesting that treatment of insomnia may improve pain. The aims of this study were to evaluate the efficacy of cognitive–behavioral therapy for insomnia (CBT‐I) in patients with knee OA, to determine whether improvements in sleep predict reduced pain, and to determine whether alterations in pain modulation mediate improvements in clinical pain.</p> </sec> <sec id="art39048-sec-0002" sec-type="section"> <title>Methods</title> <p>We conducted a randomized, double‐blind, active placebo–controlled clinical trial of CBT‐I in 100 patients with knee OA and insomnia (mean ± SD age 59.4 ± 9.5 years). Patients were randomized (1:1) to receive either 8 sessions of CBT‐I or behavioral desensitization (placebo). We conducted in‐home polysomnography (PSG), diary assessment, and sensory tests of pain modulation at baseline, posttreatment, 3 months, and 6 months.</p> </sec> <sec id="art39048-sec-0003" sec-type="section"> <title>Results</title> <p>Intent‐to‐treat analyses demonstrated substantial improvement in sleep in both groups of patients. Patients in the CBT‐I group had significantly greater reductions in wake after sleep onset (WASO), as measured by patient diary and PSG. Patients in both groups reported significant and comparable reductions in pain over 6 months, with one‐third reporting a 30% reduction in pain severity. Baseline‐to‐posttreatment reductions in WASO as measured by diary and PSG predicted subsequent decreases in clinical pain. This effect was significantly greater for CBT‐I compared with behavioral desensitization. No significant changes in laboratory measures of pain modulation were observed.</p> </sec> <sec id="art39048-sec-0004" sec-type="section"> <title>Conclusion</title> <p>Compared with active placebo, CBT‐I was efficacious in reducing sleep maintenance insomnia. CBT‐I decreased clinical pain, but not pain modulation, suggesting that it has the potential to augment pain management in knee OA. Future work is needed to identify the mechanisms by which improved sleep reduces clinical pain.</p> </sec> </abstract>